UK Markets close in 4 hrs 1 min

Cizzle Biotechnology Holdings Plc (CIZ.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
1.9500+0.0500 (+2.63%)
As of 04:18PM BST. Market open.
Currency in GBp

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 38.2500
52-week low 31.8000
50-day moving average 32.2366
200-day moving average 33.3749

Share statistics

Avg vol (3-month) 35.29M
Avg vol (10-day) 35M
Shares outstanding 5253.45M
Implied shares outstanding 6N/A
Float 864.52M
% held by insiders 144.01%
% held by institutions 12.67%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2018
Most-recent quarter (mrq)30 Jun 2021

Profitability

Profit margin -111.54%
Operating margin (ttm)-111.57%

Management effectiveness

Return on assets (ttm)-51.91%
Return on equity (ttm)-161.36%

Income statement

Revenue (ttm)25k
Revenue per share (ttm)0.08
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)25k
EBITDA -26.44k
Net income avi to common (ttm)-27.89k
Diluted EPS (ttm)-8.9000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.43M
Total cash per share (mrq)0.02
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)1.16
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A